8-KFiled 6 Nov 2026All industries
Telephone & Data Systems Inc /De/TDS
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839
Friday 6 Nov3 filings read · 3 material
8-KFiled 6 Nov 2026All industries
Telephone & Data Systems Inc /De/TDS
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
8-KFiled 6 Nov 2026Industrials
Atmus Filtration Technologies Inc.ATMU
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 net sales of $510M (+13.9% YoY), net income $61M, diluted EPS $0.74. Company raised full-year 2026 guidance and expanded share repurchase authorization from $150M to $300M, signaling confidence in cash generation and capital allocation strategy.
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net income of $163.4M ($1.82 diluted EPS) essentially flat vs. Q3 2025 ($164.2M, $1.67 EPS). Mortgage insurance in force grew modestly to $250.1B. Board declared $0.35 quarterly dividend and approved $500M share repurchase authorization through 2028.
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
Thursday 5 Nov18 filings read · 17 material
8-KFiled 5 Nov 2026All industries
Frontdoor, Inc.FTDR
8-K · Item 2.02 — Results of operations
Q3 2026: Revenue +6% to $655M, Net Income +10% to $116M, Adjusted EBITDA +5% to $205M, EPS +16% to $1.65. Full-year guidance raised. New $1B share repurchase authorization approved.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
FIGS, Inc.FIGS
8-K · Item 2.02 — Results of operations
FIGS reported Q3 2026 net revenues of $190.7M (+25.7% YoY), exceeding expectations with net income of $19.3M ($0.10 EPS) and adjusted EBITDA margin of 16.5%. Company raised full-year 2026 guidance for net revenues (~23.5% growth) and adjusted EBITDA margin (~15.8%).
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
ANI Pharmaceuticals reported Q3 2026 revenues of $290.8M (+27.6% YoY), with Cortrophin Gel up 36.1% to $138.7M. Company raised full-year EBITDA and EPS guidance and announced acquisition of Egetis Therapeutics for ~$560M to expand rare disease portfolio.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
CRA reported Q3 2026 revenue of $214.9M (+15.6% YoY), record quarterly net income of $13.9M (+21.2% YoY), and EPS of $2.20 (+27.2% YoY). Company raised full-year revenue guidance to $830–840M and narrowed EBITDA margin to 12.2–12.8%. Dividend increased 17.5%.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Banks
Resolute Holdings Management, Inc.RHLD
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026: Non-GAAP Fee-Related EPS surged to $0.69 vs. $0.13 YoY, driven by Husky Holdings management agreement (Jan 2026) and organic CompoSecure growth. Board authorized $100M share repurchase program.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026Biotech
Protagonist Therapeutics, IncPTGX
8-K · Item 2.02 — Results of operations
FDA approved MIMRYLO (rusfertide) for polycythemia vera, triggering $275M in payments to Protagonist. Q3 2026 net income $220M vs. prior-year loss of $39M. Strong cash position of $835M supports pipeline advancement and $300M share repurchase program.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
Enovis CORPENOV
8-K · Item 2.02 — Results of operations
Q3 2026: 5% organic sales growth, Reconstructive segment +6%, adjusted EBITDA and EPS guidance raised. Board approved $200M share repurchase authorization. Company executing innovation strategy despite market headwinds.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
HNST reported Q3 2026 results with 9.2% organic revenue growth, record 48.9% adjusted gross margin (+1,160 bps YoY), and raised FY2026 guidance. Company approved $30M share repurchase and generated $30.5M free cash flow YTD.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenue declined 5.4% YoY to $319.7M. Despite improved profitability metrics, company revised full-year adjusted EBITDA guidance downward to $180–200M from prior expectations, citing customer demand pushed into 2027 and memory chip pressures.
Market attention has faded.
The shares became cheaper on AIR's value read.
The gap narrowed as the filings read less positively.
The price trend weakened.
8-KFiled 5 Nov 2026Industrials
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenue of $763.7M declined 0.7% YoY; company lowered full-year 2026 guidance to $3.09B (5.1% growth) from prior range of $3.18–$3.22B. International sales fell 5.7%. Base business grew 3.0%, but overall results missed expectations.
The shares became cheaper on AIR's value read.
Attention caught up with the documented progress.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
Cogent Communications Holdings, Inc.CCOI
8-K · Item 2.02 — Results of operations
Q3 2026 service revenue declined 1.8% QoQ and 4.4% YoY to $231.2M. Off-net revenue fell 9.3% QoQ. Board suspended dividend program. Partially offset by wavelength revenue growth (+7.8% QoQ, +57% YoY) and adjusted EBITDA margin expansion to 32.0%.
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
International Seaways, Inc.INSW
8-K · Item 2.02 — Results of operations
Q3 2026 record net income of $344M ($6.90/share), driven by exceptional tanker market conditions and higher spot earnings. Fleet expansion via Bruton acquisition, strong free cash flow of $234M, and record $5.05/share dividend declared.
The filings read more positively.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026Biotech
Amphastar Pharmaceuticals, Inc.AMPH
8-K · Item 2.02 — Results of operations
Amphastar reported Q3 2026 net revenues of $207.6M (+8% YoY), GAAP net income of $37.8M (+118% YoY), and adjusted non-GAAP EPS of $1.14 (+22% YoY). Record BAQSIMI and Primatene MIST sales offset declines in epinephrine and glucagon. Gross margin compressed to 48% from 51.4% due to pricing pressure and manufacturing remediation costs.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
BlackLine reported Q3 2026 revenue of $193.4M (+8.5% YoY), GAAP operating margin of 8.6% (vs. 4.3% prior year), and non-GAAP operating margin of 25.9%. RPO grew 14.3% to $1.1B. Dollar-based NRR at 103%. Company raised full-year guidance.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
More of the market is starting to notice.
The shares became dearer on AIR's value read.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
Concentra Group Holdings Parent, Inc.CON
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenue grew 8.6% YoY to $622.1M; net income surged 36.5% YoY. Company raised FY2026 guidance across revenue, EBITDA, and FCF. Board authorized $250M share repurchase and declared $0.0625 dividend. Credit ratings upgraded.
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net sales grew 3.1% to $1.82B with improved gross margin (30.4% vs 29.9%). Adjusted EBITDA increased 1.6% to $411M. Company updated 2026 guidance: Net Sales at midpoint of prior range; Adjusted EBITDA at lower end. Authorized $300M share repurchase program.
Progress is running ahead of attention.
The price trend strengthened.
Wednesday 4 Nov20 filings read · 19 material
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Gulfport reported Q3 2026 net income of $96.4M and adjusted EBITDA of $226.5M. Production increased ~10% QoQ to 1,057.2 MMcfe/day with liquids up 67%. Signed new supply contracts for 50,000 MMBtu/d and expanded stock buyback authorization to $2.0B.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026Semiconductors
8-K · Items 2.02, 8.01 — Results of operations
VIAVI reported Q1 FY2027 results significantly above guidance with 56.9% YoY revenue growth to $469.3M, GAAP operating margin of 17.4% (+1,490 bps YoY), and GAAP net income of $76.0M (+455% YoY). Board authorized $500M share repurchase program.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Remitly reported record Q3 2026 results with 22% revenue growth to $509.8M, net income up 665% YoY to $67.6M, and Adjusted EBITDA up 97% to $120.8M. Company raised full-year 2026 outlook and increased share repurchase authorization by $300M to $500M.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026Semiconductors
8-K · Items 2.02, 8.01 — Results of operations
Cirrus Logic reported Q2 FY27 revenue of $559.5M with 53.7% gross margin, driven by strong smartphone demand and custom component adoption. Company announced $500M share repurchase authorization and provided Q3 guidance of $510–570M revenue.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
Mks IncMKSI
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026: Record revenue $1,413M (+43% YoY), record net income $236M, record EPS $3.26, all above guidance. Strong growth across Semiconductor (+54% YoY) and Electronics & Packaging (+43% YoY). $500M share repurchase program approved.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Veracyte, Inc.VCYT
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenue grew 15% YoY to $151.8M with testing revenue at $146.4M. GAAP net income $31.5M (20.8% margin) and adjusted EBITDA $41.2M (27.2% margin). Company announced $100M share repurchase program. 2026 guidance narrowed slightly.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
Ridgepost Capital reported Q3 2026 results with fee-paying AUM up 21% YoY to $35.2B, fee-related revenue up 17% YoY, and fee-related earnings up 19% YoY. Board approved $30M share repurchase increase and declared $0.04/share dividend.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Q3 2026: Net sales +30% YoY to $202.9M, net income +46% to $16.0M, adjusted EBITDA margin expanded 110bps to 20.2%. Full-year guidance raised for second consecutive quarter. $100M share repurchase authorized.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Rayonier IncRYN
8-K · Item 2.02 — Results of operations
Q3 2026: Net income $123.3M ($0.41/share); pro forma $40.0M ($0.13/share). Adjusted EBITDA $144.6M. Completed $291M timberland transactions with RMS. Repurchased $59.8M shares; approved new $300M repurchase program.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
CoreCivic reported Q3 2026 strong results: revenue up 28.2% YoY, occupancy increased to 84% from 76.7%, sold four facilities for $2.2B generating $1.8B gain, repaid $700M+ debt reducing leverage to (0.1)x, and expanded share repurchase authorization by $500M.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Ardent Health reported Q3 2026 net income of $45M vs. prior-year loss of $23M, with adjusted EBITDA of $138M. Company raised full-year 2026 adjusted EBITDA guidance midpoint by 1.5% to $500–535M, citing strong operational execution, 2.9% adjusted admissions growth, and $70M+ in IMPACT cost savings.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
Riley Exploration Permian, Inc.REPX
8-K · Items 1.01, 2.02, 2.03 — Material agreement
Riley Permian amended credit facility (borrowing base $425M→$450M, maturity extended to Oct 2030), retired $130M senior notes, and reported Q3 production up 20% QoQ (+38% YoY) to 25.4 MBbls/d with $111M operating cash flow and $42M free cash flow.
The filings read more positively.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026Industrials
Adient plcADNT
8-K · Items 1.01, 3.03 — Material agreement
Adient's board approved a $400M increase in share repurchase authorization (total $1B) and adopted a Tax Benefits Preservation Plan to protect ~$3.5B in NOL carryforwards from Section 382 ownership-change limitations.
The filings read more positively.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
American Financial Group IncAFG
8-K · Items 2.02, 8.01 — Results of operations
AFG reported Q3 2026 record core net operating earnings of $3.97 per share (48% YoY increase), record P&C pretax operating income of $406M, 9% premium growth, and declared a $3.50 special dividend ($290M aggregate). Annualized core operating ROE of 26%.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 results show 48% sales volume growth, 76% Adjusted EBITDA increase to $124M, net income of $49.3M, and $166M operating cash flow. Company declared $2.00/share special dividend, demonstrating strong cash generation from Blue Creek mine ramp-up ahead of schedule.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026Industrials
Stanley Black & Decker, Inc.SWK
8-K · Item 2.02 — Results of operations
SWK reported Q3 2026 results with 4% organic growth, 760 bps gross margin expansion, and raised full-year 2026 EPS guidance significantly (113% GAAP growth at midpoint). Board approved $1B share repurchase authorization.
No notable change in AIR's read.
8-KFiled 4 Nov 2026Banks
Hut 8 Corp.HUT
8-K · Item 2.02 — Results of operations
Hut 8 reported Q3 2026 results with full commercialization of Beacon Point AI data center campus, $26.6B in expected contract value, 1,300 MW capacity under exclusivity, $1.07B credit facility, and $250M shareholder returns via buybacks.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Grand Canyon Education, Inc.LOPE
8-K · Item 2.02 — Results of operations
GCE reported Q3 2026 results with 185.6% operating income growth to $51.5M, driven by 5.2% enrollment increase to 145,270 students. Net income rose 164.3% to $43.0M. Board approved $355M share repurchase increase. Full-year guidance provided.
No notable change in AIR's read.
8-KFiled 4 Nov 2026Industrials
Insulet CorpPODD
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $842M grew 19.2% (19.6% constant currency), beating guidance high-end. Operating margin expanded 590 bps. Company authorized $1B share repurchase program with $400M allocated to Q4 2026. Full-year guidance raised for Omnipod segments.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
Tuesday 3 Nov12 filings read · 9 material
8-KFiled 3 Nov 2026All industries
8-K · Items 2.02, 5.02 — Results of operations
Yum China reported Q3 2026 results with 8% revenue growth, 13% operating profit growth, and 20% diluted EPS growth. Achieved record net new store openings (692 quarterly), 15th consecutive quarter of same-store transaction growth, and 10th consecutive quarter of OP margin expansion.
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 3 Nov 2026All industries
Weyco Group IncWEYS
8-K · Item 2.02 — Results of operations
Q3 2026 net sales up 5% to $77.0M; net earnings nearly doubled to $11.5M from $6.6M YoY. Gross margin improved to 49.7% (vs 40.7%), driven by lower tariffs and $3.3M refunds. Board declared $2.00 special dividend per share.
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 3 Nov 2026All industries
8-K · Item 2.02 — Results of operations
DiamondRock reported Q3 2026 results exceeding expectations with 65.7% net income growth, 12.5% comparable hotel EBITDA growth, and 6.6% RevPAR increase. Company raised full-year guidance and acquired The Bellmoor Inn & Spa for $31M at attractive 8.6% cap rate.
Progress is running ahead of attention.
8-KFiled 3 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 production beat guidance at 230,470 BOE/day (+10% YoY). Oil and gas revenues reached record $1.22B (+51% YoY). Company repaid $150M debt, raised dividend 17%, and increased full-year guidance. Reserves grew 16% to 771M BOE.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 3 Nov 2026All industries
JBT MAREL CorpJBTM
8-K · Item 2.02 — Results of operations
JBT Marel reported Q3 2026 record net income margin (7.0%) and adjusted EBITDA margin (18.0%), beat guidance, and announced $500M increase to share repurchase program (now $700M total). Revenue declined 1% due to lower CPG book-and-ship volume, but margins improved 90 bps YoY.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 3 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Jackson Financial reported Q3 2026 results with record retail annuity sales of $6.5B (+22% YoY), adjusted operating earnings of $517M (+19% YoY), and robust capital generation of $281M. AARP partnership announced as exclusive annuity provider.
More of the market is starting to notice.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 3 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
Leidos reported Q3 2026 revenues of $4.6B (+4% YoY), net income $413M (+12% YoY), and non-GAAP diluted EPS $3.62 (+19% YoY). Company raised full-year 2026 guidance for the third consecutive quarter. Strong bookings of $5.5B (1.2x book-to-bill) and $49.6B backlog.
Progress is running ahead of attention.
8-KFiled 3 Nov 2026Software / SaaS
Procore Technologies, Inc.PCOR
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $402M (+19% YoY) exceeded guidance high-end; non-GAAP operating margin 23%. Company raised full-year 2026 and 2027 revenue/margin guidance. GRR 95%, $100K+ ARR customers +14% YoY. DroneDeploy acquisition completed.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 3 Nov 2026Software / SaaS
8-K · Items 2.02, 8.01 — Results of operations
Dynatrace reported Q2 FY2027 results with 16% ARR growth to $2.21B and 17% revenue growth. Completed Arize acquisition, announced $1B share repurchase program, and guided FY2027 ARR growth upward by 150–200 bps. Investor Day scheduled for February 2027.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
Monday 2 Nov5 filings read · 5 material
8-KFiled 2 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Herbalife reported Q3 2026 net sales of $1.35B (+6.0% YoY), beating guidance with adjusted EBITDA of $182.4M (+70 bps margin). Fifth consecutive quarter of growth; full-year sales guidance raised. New $250M share repurchase program authorized.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 2 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $127.3M (+30% YoY) with 94% gross margin. KB113 shows >80% BCC regression in Gorlin syndrome. $1.2B cash position. Board authorizes $400M share repurchase program.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 2 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Jazz Pharmaceuticals reported Q3 2026 revenues of $1.2B (+10% YoY), raised full-year guidance to $4.775–$4.85B, achieved FDA approval and rapid Ziihera launch in HER2+ GEA, and closed Actio acquisition adding ABS-1230 to rare epilepsy portfolio.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 2 Nov 2026Industrials
FabrinetFN
8-K · Item 2.02 — Results of operations
Fabrinet reported record Q1 FY2027 revenue of $1,474.5M (+51% YoY), exceeding guidance. Non-GAAP EPS of $4.34 beat expectations. Board expanded share repurchase authorization by $103M. Q2 guidance projects continued strong performance.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
8-KFiled 2 Nov 2026All industries
8-K · Item 2.02 — Results of operations
CRC reported Q3 2026 results with 152 MBoe/d production (2% QoQ growth), $341M adjusted EBITDAX exceeding guidance, $147M free cash flow, 4% dividend increase to $0.42/share, and completed Crimson Midstream acquisition while announcing Uinta Basin divestiture.
Progress is running ahead of attention.
The price trend weakened.
Thursday 5 Nov18 filings read · 17 material
8-KFiled 5 Nov 2026Banks
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
Wednesday 4 Nov20 filings read · 19 material
8-KFiled 4 Nov 2026All industries
Cbl & Associates Properties IncCBL
8-K · Item 8.01 — Other events
No notable change in AIR's read.
Tuesday 3 Nov12 filings read · 9 material
8-KFiled 3 Nov 2026Biotech
8-K · Item 8.01 — Other events
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 3 Nov 2026All industries
Weyco Group IncWEYS
8-K · Item 8.01 — Other events
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 3 Nov 2026All industries
XMax Inc.XMAX
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
The price trend weakened.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.